Next 10 |
Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its...
Scinai Publishes Q1 2024 Financial Results and Provides Business Update PR Newswire JERUSALEM , July 2, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing inflamma...
New research has determined that the global effect of the coronavirus pandemic observed over the last four years has led to a heightened surge of other infectious illnesses. The research was conducted by Airfinity, a data and analytics company based in the United Kingdom, which is focused on...
A look at the top 10 most actives in the United States Mustang Bio Inc. (MBIO) rose 476.9% to $0.75 on volume of 1,104,730,765 shares NVIDIA Corporation (NVDA) fell 0.7% to $130.98 on volume of 283,604,651 shares ENDRA Life Sciences Inc. (NDRA) rose 34.2% to $0.139 on volume of 219,783,92...
2024-06-17 15:58:01 ET More on Scinai Immunotherapeutics Financial information for Scinai Immunotherapeutics Read the full article on Seeking Alpha For further details see: Scinai stock rallies in wake of updated corporate presentation
A look at the top 10 most actives in the United States Mustang Bio Inc. (MBIO) rose 141.4% to $0.3138 on volume of 161,736,322 shares ENDRA Life Sciences Inc. (NDRA) rose 13.7% to $0.117778 on volume of 79,058,950 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 27.2% to $0.1042 on volum...
Windtree Therapeutics Inc. (WINT) is expected to report for Q1 2024 CohBar Inc. (CWBR) is expected to report for Q1 2024 hopTo Inc (HPTO) is expected to report for Q1 2024 Bitech Technologies Corporation (BTTC) is expected to report for Q1 2024 Roadzen Inc. (RDZN) is expected to r...
Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its...
Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity. PR Newswire JERUSALEM , June 13, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: ...
Gelesis Holdings, Inc. (GLSHQ) is expected to report for Q1 2024 EVmo Inc (YAYO) is expected to report for Q1 2024 Chiba Bank Ltd. ADR (CHBAY) is expected to report for Q4 2024 Spark Networks SE (LOVLQ) is expected to report for Q1 2024 ToughBuilt Industries Inc. (TBLT) is expecte...
News, Short Squeeze, Breakout and More Instantly...
Scanner Technologies Corp Company Name:
SCNI Stock Symbol:
OTCMKTS Market:
Scanner Technologies Corp Website:
Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through its...
Scinai Publishes Q1 2024 Financial Results and Provides Business Update PR Newswire JERUSALEM , July 2, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai", or the "Company"), a biopharmaceutical company focused on developing inflamma...
New research has determined that the global effect of the coronavirus pandemic observed over the last four years has led to a heightened surge of other infectious illnesses. The research was conducted by Airfinity, a data and analytics company based in the United Kingdom, which is focused on...